Development and preclinical validation of novel PAR2 inhibitors for the treatment of Osteoarthritis

McIntosh, Katy (Principal Investigator)
Crilly, Anne (Co-investigator)
Jamieson, Craig (Co-investigator)
Plevin, Robin (Co-investigator)
Rattray, Zahra (Co-investigator)

Project: Research

Status	Finished
Effective start/end date	1/04/20 → 30/09/22

Funding

Tenovus Scotland: £17,500.00

Proteinase activated receptor 2: a novel therapeutic drug target
Lozon, Y., McIntosh, K. & Plevin, R., 8 Feb 2024.
Research output: Contribution to conference › Poster
Working towards proteinase activated receptor-2 antagonists
McIntosh, K. A., Jamieson, C. & Plevin, R. J., 13 Dec 2015. 1 p.
Research output: Contribution to conference › Abstract › peer-review

Frontiers in Immunology (Journal)
McIntosh, K. (Peer reviewer)
5 Jul 2024
Activity: Publication Peer-Review and Editorial Work › Journal peer review
A history of PAR2 drug design
McIntosh, K. (Speaker)
9 Dec 2020
Activity: Talk or Presentation › Invited talk